Adamas is a fully-integrated company with deep expertise in the development and commercialization of neurological therapies.
Total raised: $40M
Founded date: 2002
Investors 1
Date | Name | Website |
- | DAG Ventur... | dagventure... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
19.08.2009 | - | $40M | - | venturebea... |
Mentions in press and media 13
Date | Title | Description | Category | Author | Source |
23.11.2021 | Supernus P... | ROCKVILLE, Md., Nov. 23, 2021 ... | - | - | marketscre... |
12.10.2021 | Adamas Pha... | Supernus Pharmaceuticals to Ac... | - | - | marketscre... |
11.10.2021 | Adamas Pha... | Acquisition of two marketed pr... | - | - | marketscre... |
12.05.2021 | Adamas Pha... | First quarter 2021 total reven... | - | - | marketscre... |
12.05.2021 | ADAMAS PHA... | First quarter 2021 total reven... | - | - | marketscre... |
01.03.2021 | Adamas Pha... | EMERYVILLE, Calif.--(BUSINESS ... | - | - | oaoa.com/n... |
24.02.2021 | Adamas Pha... | EMERYVILLE, Calif.--(BUSINESS ... | - | - | oaoa.com/n... |
11.05.2017 | Astellas ... | → Japan’s Astellas Pharma is... | - | Shehla Sha... | endpts.com... |
29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |
19.08.2009 | Adamas sco... | Adamas Pharmaceuticals, one of... | - | - | venturebea... |
Show more